---
title: "Bonn Scientists 'Reset' Biological Clock of 101-Year-Old Donor's Cells: Epigenetic Age Dropped to 5% Without Embryonic Stage"
description: "University of Bonn scientists have shown that blood cells from a 101-year-old donor can be rejuvenated to 5% of their initial epigenetic age without transitioning to an embryonic state. The process took about 50 days."
date: 2026-11-15T14:23:42.374Z
lang: en
url: https://xab.info/en/posts/bonn-scientists-cell-rejuvenation-epigenetic-age
tags: [cell-rejuvenation, epigenetics, stem-cells, aging-research, university-of-bonn, dna-methylation, neural-stem-cells]
author: "Alexander Buran"
publisher: "XAB.info"
---

# Bonn Scientists 'Reset' Biological Clock of 101-Year-Old Donor's Cells: Epigenetic Age Dropped to 5% Without Embryonic Stage

![Microscopic view of neural stem cells and red blood cells, illustrating the cell rejuvenation process.](https://xab.info/media/2026/11/15/bonn-university-cell-rejuvenation-epigenetic-age-5-percent/bonn-university-cell-rejuvenation-epigenetic-age-5-percent-1.webp)

## Key Points

- The epigenetic age of a 101-year-old donor's cells dropped to 13%, and further to 5% of the original value with cultivation
- Reprogramming was performed with two factors (SOX2, cMYC) without passing through an embryonic state
- Rejuvenation took about 50 days and is not dependent on intense cell division
- Independent markers of aging disappeared: autophagy impairment, nuclear changes, senescence markers
- Clinical application for humans is distant: the mechanism is not established, and safety in vivo is not proven

Researchers at the University of Bonn and the University Hospital Bonn have published results of an experiment that could redefine our understanding of how cells shed age-related changes. The team derived induced neural stem cells from blood samples of donors ranging from newborns to 101 years old and demonstrated that the epigenetic age of the oldest participants' cells dropped to 13% of the initial value, and further to 5% with continued cultivation. Based on the biological clocks used, only a negligible fraction of age-related changes remained in the cells. The work, published in the journal Aging Cell, is the first to track the process of cellular rejuvenation in stages rather than recording it as an instantaneous jump.

### Two Factors Instead of Full Reprogramming

To convert blood cells into neural stem cells, researchers used only two reprogramming factors — SOX2 and cMYC. Unlike the classic method of creating induced pluripotent stem cells (iPSC), which employs a set of four or more factors (including Oct4 and Klf4), this procedure does not require the cell to pass through a state close to the embryonic. The resulting neural stem cells can give rise to neurons, astrocytes, and oligodendrocytes, but do not turn into universal pluripotent cells. This is crucial from a safety perspective: pluripotent cells can differentiate into almost any tissue type, and their uncontrolled proliferation, combined with active reprogramming factors, is linked to a risk of teratomas and other tumors. By bypassing the embryonic stage, Bonn scientists eliminate one of the key barriers to potential therapeutic application.

### Fifty Days of Gradual 'Reset'

The most unexpected result of the work was the duration of the rejuvenation. Classic reprogramming into a pluripotent state occurs relatively quickly—within a matter of days. In the case of neural stem cells, however, age-related epigenetic marks disappeared gradually, with the bulk of the changes taking about 50 days. Scientists tracked this process via DNA methylation—chemical markers located on the DNA molecule used by specialized algorithms to estimate biological cell age. The ability to observe the process in dynamics makes this work unique: previous fast reprogramming did not allow for dissecting rejuvenation into individual stages or determining which molecular mechanisms are triggered first and which occur at the final stage.

### Cell Division Is Not the Engine of Rejuvenation

A separate block of experiments tested the hypothesis that the decline in epigenetic age might simply be a consequence of intense division: old cells divide repeatedly, and 'fresh' cells with low age accumulate in the population. Researchers slowed down multiplication using special substances, and in a separate experiment, forced a portion of cells to transition to neuronal specialization, which also limits proliferation. In both cases, the epigenetic age decline continued. This means the disappearance of age markers cannot be explained by a simple replacement of old cells with new ones. The precise molecular mechanism triggering the 'reset' of the epigenetic clock remains a subject for further research.

### Caveats and Interpretation Limits

The authors emphasize an important caveat: epigenetic age is not a direct measure of a cell's functional state. Changes in cellular specialization itself can influence biological clock readings, and nerve cells and blood cells have different age characteristics. The researchers admit that this might inflate the degree of observed rejuvenation. Nevertheless, changes affected not only epigenetic clock readings: the resulting neural stem cells also lost other independent signs of aging, including characteristic changes in the cell nucleus, autophagy impairment, and senescence markers. The combination of these data makes the conclusion of real rejuvenation more convincing than if it relied solely on one type of biomarker.

### What This Means for Aging Medicine

The main significance of the work is the emergence of a model in which one can verify in detail which molecular mechanisms trigger cellular rejuvenation and which factors influence it. In the future, this could help develop ways to restore aging tissues and treat age-related diseases. However, as the researchers themselves note, anti-aging procedures for humans are still a long way off: the mechanism of the process is not established, and the safety of a similar effect in a living organism has not been proven. Nevertheless, the publication in Aging Cell and confirmation of results by several independent outlets indicate that the work has passed a full peer-review cycle and gained recognition from the scientific community. For the Bonn team, this is just the first step: now they must figure out exactly what happens in the cell on each of the fifty days of the 'reset' and whether this process can be replicated under clinical conditions.

## Fact-Check & Sources

- [Клетки 101-летнего человека омолодили почти до эмбрионального состояния: учёные нашли способ повернуть их биологические часы назад](https://www.ixbt.com/news/2026/11/15/kletki-101-letnego-celoveka-omolodili-pocti-do-embrionalnogo-sostoianiia-ucenye-nasli-sposob-povernut-ix-biologiceskie-casy-nazad.html) - Primary source, full study text. The title contains sensationalist phrasing that does not reflect reality (the cells did not become embryo-like), but the factual part of the article is correct.
- [Перепрограммирование без промежуточного этапа: учёные нашли способ омолаживать клетки человека](https://www.obozrevatel.com/section-nauka-oboz/news-pereprohramuvannya-bez-promizhnoho-etapu-vcheni-znayshly-sposib-omolodzhuvaty-lyudski-klityny-20-10-2026.html) - Confirms the involvement of the University of Bonn and University Hospital Bonn, emphasizing the absence of the embryonic stage.
- [Появился способ «омолодить» клетки человека на 60 лет](https://hi-tech.mail.ru/news/158636-krov-80-letnego-prevratili-v-molodye-stvolovye-kletki-mozga/) - Confirms the transformation of an elderly person's blood cells into neural stem cells. The '60 years' figure is a simplified interpretation of the percentage reduction in epigenetic age.
- [Ученым впервые удалось омолодить клетки более чем на 60 лет](https://www.gazeta.ru/science/news/2026/10/22/29579575.shtml) - Points to the publication in Aging Cell, working with blood cells from an 80-year-old donor. The 'over 60 years' figure is consistent with the percentage reduction for a specific donor age.

## FAQ

### What exactly did the University of Bonn scientists do?

Researchers transformed blood cells from donors (ranging from newborns to 101 years old) into neural stem cells using two reprogramming factors—SOX2 and cMYC. During this process, the epigenetic age of the elderly donors' cells dropped to 13%, and subsequently to 5% of the original.

### Why is this different from the classic iPSC method?

The classic method for obtaining induced pluripotent stem cells requires the cell to pass through an embryonic state and is associated with tumor formation risks. The new method bypasses this stage: the cells become neural stem cells, not universal pluripotent ones.

### How long does the rejuvenation process take?

The main part of the changes takes about 50 days. This is significantly longer than classic reprogramming into a pluripotent state, which allowed the scientists to track the process in stages for the first time.

### Can this method be used to treat humans yet?

No. The researchers emphasize that the mechanism of the process is not established, and the safety of a similar effect in a living organism has not been proven. The work is fundamental and aimed at understanding the mechanisms of cellular aging.

### Are the rejuvenation data reliable?

The authors note that epigenetic age is not a direct measurement of a cell's functional state, and specialization remodeling can influence biological clock readings. However, other independent aging markers—autophagy impairment, nuclear changes, senescence signs—also disappeared, making the conclusion more convincing.